How to treat anemia with ‘vitamin D’
As the American heart attacks epidemic continues to plague the nation, some are turning to a less popular but still powerful antioxidant: vitamin D. The National Institutes of Health recently awarded a $10 million grant to a team of researchers at the University of North Carolina at Chapel Hill to develop a novel vitamin D-based blood thinning therapy that uses the vitamin to treat the common cold, which can be triggered by high levels of the vitamin.
And the team hopes to roll out the device by the end of the year.
Vitamin D, which is a type of vitamin D in the sunlight, plays a crucial role in regulating a person’s body’s immune system and can help keep your body and your mind in optimal condition.
It is also one of the most common nutrients found in the human body, and its importance in preventing and treating chronic disease has been well-documented.
Studies have shown that if you consume enough vitamin D, you can significantly reduce your risk of developing certain types of cancer.
According to the National Institutes, vitamin D can help control certain types or types of inflammation in your body.
In fact, studies show that it can help people living with the common Cold.
Scientists have been looking into ways to use vitamin D to treat this condition for decades.
For instance, researchers have been using vitamin D supplements to prevent and treat type 2 diabetes, which increases blood sugar levels, in addition to treating high blood pressure, which causes weight gain and can cause strokes and heart attacks.
Researchers have also been testing vitamin D supplementation to prevent the common and life-threatening colds, but this hasn’t been widely available to the public.
A study conducted by the American Heart Association found that about 90 percent of Americans are deficient in vitamin D3, which has been shown to protect against type 2 diabetics.
“I think a lot of people are looking for a quick and easy solution to reduce the number of cases of the common-cold virus and to prevent people from going to the doctor with their colds,” said Dr. Michael R. Wolski, a professor of preventive medicine at the Johns Hopkins University School of Medicine.
While the device developed by the North Carolina team is being tested in the United States, it may ultimately work for other countries, including the United Kingdom, Denmark, Australia, New Zealand and Canada.
More on the common health pandemic:The National Health and Medical Research Council has also awarded the NCR $8 million to develop an oral vitamin D capsule for children and young adults that could help reduce the numbers of colds in the future.
With these additional resources, the NCF is aiming to produce a clinical trial in the next two to four years, Wolsski said.
He added that the NCRC hopes to make the oral capsule available in the coming months.
However, there is still a lot more work to be done before the vaccine can be tested in humans.
Until then, the researchers say they are looking forward to seeing the effects of the oral vitamin in people, especially those who have chronic health conditions such as arthritis, diabetes, heart disease, depression and obesity.